Effect of a single dose of methyl prednisolone as rescue medication for patients who develop hypotensive dengue shock syndrome during the febrile phase: A retrospective observational study

International Journal of Infectious Diseases

Volumn 15, Issue 6, 2011, Pages

  Premaratna, R ^a   Jayasinghe, K G N U ^a   Liyanaarachchi, E W ^a   Weerasinghe, O M S ^a   Pathmeswaran, A ^a   de Silva, H J ^a  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; METHYLPREDNISOLONE;

ADULT; ASCITES; CLINICAL PROTOCOL; COLLOID; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRYSTALLOID; DENGUE; DRUG EFFECT; FEMALE; FEVER; FLUID THERAPY; HUMAN; HYPOTENSION; HYPOTENSIVE DENGUE SHOCK SYNDROME; LETTER; MALE; MORTALITY; OBSERVATIONAL STUDY; PLEURA EFFUSION; PULSE PRESSURE; RETROSPECTIVE STUDY; SHOCK; SINGLE DRUG DOSE; SRI LANKA; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE TRANSFUSION; WORLD HEALTH ORGANIZATION;

ADULT; DENGUE; DENGUE HEMORRHAGIC FEVER; FEMALE; FEVER; HUMANS; MALE; METHYLPREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79955955055     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.03.006     Document Type: Letter

References (10)

1. Epidemiological Unit, Colombo, Sri Lanka. Flashback 2009. Weekly epidemiological report 2010: 37: 1. (). http://www.epid.gov.lk/pdf/WER%2520%25202010/Vol%252037%2520NO%252001a%2520%2520English.pdf.
2. Reis S.R., Sampaio A.L., Henriques M.G., Gandini M., Azeredo E.L., Kubelka C.F. An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation. Mem Inst Oswaldo Cruz 2007, 102:983-990.
3. Meduri G.U., Headley A.S., Golden E., Carson S.J., Umberger R.A., Kelso T, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159-165.
4. Panpanich R., Sornchai P., Kanjanaratanakorn K. Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev 2006, 3. CD003488.
5. Rajapakse S. Corticosteroids in the treatment of dengue illness. Trans R Soc Trop Med Hyg 2009, 103:122-126.
6. Sumarmo, Talogo W., Asrin A., Isnuhandojo B., Sahudi A. Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982, 69:45-49.
7. Tassniyom S., Vasanawathana S., Chirawatkul A., Rojanasuphot S. Failure of high dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993, 92:111-115.
8. Futrakul P., Poshyachinda M., Mitrakul C. Hemodynamic response to high-dose methyl prednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement. Southeast Asian J Trop Med Public Health 1987, 18:373-379.
9. Futrakul P., Vasanauthana S., Poshyachinda M., Mitrakul C., Cherdboonchart V., Kanthirat V. Pulse therapy in severe form of dengue shock syndrome. J Med Assoc Thai 1981, 64:485-491.
10. World Health Organization Guidelines for treatment of dengue fever/dengue haemorrhagic fever in small hospitals 1999, WHO, New Delhi.